| OCUGEN INC. DL-,001 |
| USA |
| Gesundheit |
| US67577C1053 / A2PSZH |
| 2H51 (Frankfurt) / OCGN (NASDAQ) |
| FRA:2H51, ETR:2H51, 2H51:GR, NASDAQ:OCGN |
| - |
| https://ocugen.com/ |
|
Ocugen Inc. is a biopharmaceutical company focused..
>Volltext.. |
| 404.75 Mio. EUR |
| 409.69 Mio. EUR |
| 4.11 Mio. EUR |
| -45.22 Mio. EUR |
| -49.2 Mio. EUR |
| -0.17 EUR |
| 28.36 Mio. EUR |
| 23.34 Mio. EUR |
| -44.69 Mio. EUR |
| 1.5 |
| 21.29% |
| 1.08% |
| - |
| - |
| - |
| - |
| OCUGEN |
| 02.11.25 |
|